Advancing global tuberculosis control after the UNGA-HLM

According to the WHO report,1 in 2017 there was a shortfall of US$3·5 billion of the estimated budget required for tuberculosis prevention and care in low-income and middle-income countries. In addition to budgetary issues, global tuberculosis control efforts are unlikely to succeed unless the under...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 392; no. 10153; pp. 1096 - 1097
Main Authors Marais, Ben, Zumla, Alimuddin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 29.09.2018
Elsevier Limited
Subjects
Funding
Health care access
R&D
Research & development
Tuberculosis
New York
United States > US
Philippines
Zambia
India
Bangladesh
Pakistan
Namibia
China
South Africa
Zimbabwe
Nigeria
Lesotho
Indonesia
Online AccessGet full text

Cover

More Information
Summary:According to the WHO report,1 in 2017 there was a shortfall of US$3·5 billion of the estimated budget required for tuberculosis prevention and care in low-income and middle-income countries. In addition to budgetary issues, global tuberculosis control efforts are unlikely to succeed unless the underlying socioeconomic determinants of the tuberculosis outbreak are addressed.3,4 Achieving universal coverage and access to health care is an acknowledged human right. Increased resources are essential for advancing and facilitating cross-continent research collaborations on development of new diagnostics, drugs, and oral treatment regimens and for reducing duration of therapy and improving treatment outcomes for all forms of tuberculosis.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
ISSN:0140-6736
1474-547X
1474-547X
DOI:10.1016/S0140-6736(18)32361-4